Bluejay Diagnostics Files Q1 2025 10-Q
Ticker: BJDX · Form: 10-Q · Filed: 2025-05-13T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Bluejay Diagnostics filed its Q1 2025 10-Q on 5/13/25. Check financials.
AI Summary
Bluejay Diagnostics, Inc. filed its 10-Q for the quarterly period ended March 31, 2025. The company, incorporated in Delaware with its principal executive offices in Acton, MA, reported its financial status. The filing was made on May 13, 2025, under SEC file number 001-41031.
Why It Matters
This filing provides investors with an update on Bluejay Diagnostics' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing and does not inherently present new risks.
Key Numbers
- 001-41031 — SEC File Number (Identifies the specific filing for Bluejay Diagnostics, Inc.)
Key Players & Entities
- Bluejay Diagnostics, Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- May 13, 2025 (date) — Filing date
- 001-41031 (other) — SEC file number
- Delaware (other) — State of incorporation
- Acton, MA (location) — Principal executive offices
FAQ
What is the reporting period for this 10-Q filing?
The quarterly period ended March 31, 2025.
When was this 10-Q filed with the SEC?
The filing date was May 13, 2025.
What is the company's SEC file number?
The SEC file number is 001-41031.
In which state was Bluejay Diagnostics, Inc. incorporated?
Bluejay Diagnostics, Inc. was incorporated in Delaware.
What is the principal executive office address for Bluejay Diagnostics, Inc.?
The principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.
From the Filing
0001213900-25-042633.txt : 20250513 0001213900-25-042633.hdr.sgml : 20250513 20250513160145 ACCESSION NUMBER: 0001213900-25-042633 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 65 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250513 DATE AS OF CHANGE: 20250513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bluejay Diagnostics, Inc. CENTRAL INDEX KEY: 0001704287 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 473552922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41031 FILM NUMBER: 25939825 BUSINESS ADDRESS: STREET 1: 360 MASSACHUSETTS AVENUE, SUITE 203 CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: (978) 631-0152 MAIL ADDRESS: STREET 1: 360 MASSACHUSETTS AVENUE, SUITE 203 CITY: ACTON STATE: MA ZIP: 01720 10-Q 1 ea0241317-10q_bluejay.htm QUARTERLY REPORT     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 10-Q   (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the quarterly period ended March 31, 2025   OR   ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the transition period from __________ to__________   Commission file number: 001-41031   Bluejay Diagnostics, Inc. (Exact Name of Registrant as Specified in Its Charter)   Delaware   47-3552922 (State or Other Jurisdiction of Incorporation or Organization)   (I.R.S. Employer Identification No.)   360 Massachusetts Avenue , Suite 203 , Acton , MA   01720 (Address of Principal Executive Offices)   (Zip Code)   (844) 327-7078 (Registrant’s Telephone Number, Including Area Code)     (Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)   Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐   Indicate by check mark whether the registrant has submitted electronically if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐   Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.   Large Accelerated Filer ☐ Accelerated Filer ☐ Non-Accelerated Filer ☒ Smaller Reporting Company ☒   Emerging Growth Company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   Securities registered pursuant to Section 12(b) of the Exchange Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock   BJDX   The Nasdaq Capital Market LLC   Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒   The registrant had 1,494,182 shares of common stock outstanding at May 12, 2025.